{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:21:38Z","timestamp":1769264498466,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471222"],"award-info":[{"award-number":["81471222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholars Construction Engineering of Shandong Province","award":["ts20130914"],"award-info":[{"award-number":["ts20130914"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.molimm.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T19:05:00Z","timestamp":1515697500000},"page":"200-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis"],"prefix":"10.1016","volume":"94","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-tao","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong-cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-chun","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-sheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.molimm.2018.01.005_bib0005","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2018.01.005_bib0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2015.11.010","article-title":"Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides","volume":"105","author":"Bayik","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molimm.2018.01.005_bib0015","doi-asserted-by":"crossref","first-page":"217297","DOI":"10.1155\/2013\/217297","article-title":"In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction","volume":"2013","author":"Boehm","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.molimm.2018.01.005_bib0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","article-title":"Increased expression of toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection","volume":"221","author":"Cavalcante","year":"2016","journal-title":"Immunobiology"},{"issue":"11","key":"10.1016\/j.molimm.2018.01.005_bib0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13238-015-0210-0","article-title":"Phenotypic Tfh development promoted by CXCR5-controlled re-localization and IL-6 from radiation-resistant cells","volume":"6","author":"Chen","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.molimm.2018.01.005_bib0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.molimm.2018.01.005_bib0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ni.1837","article-title":"Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation","volume":"11","author":"Crotty","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2018.01.005_bib0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2018.01.005_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2010.10.007","article-title":"Regulation of T follicular helper cell formation and function by antigen presenting cells","volume":"23","author":"Deenick","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2018.01.005_bib0050","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaci.2014.08.012","article-title":"Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of T(H)1\/T(FH) signatures","volume":"135","author":"de Wit","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.molimm.2018.01.005_bib0055","doi-asserted-by":"crossref","first-page":"e44531","DOI":"10.1371\/journal.pone.0044531","article-title":"Vascular dysfunction following polymicrobial sepsis: role of pattern recognition receptors","volume":"7","author":"Ehrentraut","year":"2012","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.molimm.2018.01.005_bib0060","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6813","key":"10.1016\/j.molimm.2018.01.005_bib0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molimm.2018.01.005_bib0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.immuni.2008.05.016","article-title":"Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms","volume":"29","author":"Hou","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.molimm.2018.01.005_bib0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2011.01.011","article-title":"Selective utilization of toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response","volume":"34","author":"Hou","year":"2011","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.molimm.2018.01.005_bib0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J. Exp. Med."},{"issue":"7335","key":"10.1016\/j.molimm.2018.01.005_bib0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2018.01.005_bib0090","doi-asserted-by":"crossref","first-page":"381418","DOI":"10.1155\/2014\/381418","article-title":"Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"2014","author":"Klonowska-Szymczyk","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.molimm.2018.01.005_bib0095","doi-asserted-by":"crossref","first-page":"e0146326","DOI":"10.1371\/journal.pone.0146326","article-title":"Proinflammatory stimulation of toll-like receptor 9 with high dose CpG ODN 1826 impairs endothelial regeneration and promotes atherosclerosis in mice","volume":"11","author":"Krogmann","year":"2016","journal-title":"PLoS One"},{"issue":"5\u20136","key":"10.1016\/j.molimm.2018.01.005_bib0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molimm.2018.01.005_bib0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mcn.2015.08.010","article-title":"Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis","volume":"68","author":"Li","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.molimm.2018.01.005_bib0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mcn.2016.05.001","article-title":"ROCK inhibitor abolishes the antibody response in experimental autoimmune myasthenia gravis","volume":"74","author":"Li","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.molimm.2018.01.005_bib0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.molimm.2018.01.005_bib0120","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00395-013-0376-7","article-title":"Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia\/reperfusion injury via IL-10 up-regulation","volume":"108","author":"Markowski","year":"2013","journal-title":"Basic Res. Cardiol."},{"issue":"11","key":"10.1016\/j.molimm.2018.01.005_bib0125","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.4049\/jimmunol.1501463","article-title":"IL-21 and IL-4 collaborate to shape T-dependent antibody responses","volume":"195","author":"McGuire","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2018.01.005_bib0130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2007.08.017","article-title":"Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids","volume":"27","author":"Paget","year":"2007","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.molimm.2018.01.005_bib0135","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI26078","article-title":"Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis","volume":"116","author":"Prinz","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.molimm.2018.01.005_bib0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"31","key":"10.1016\/j.molimm.2018.01.005_bib0145","doi-asserted-by":"crossref","first-page":"E3224","DOI":"10.1073\/pnas.1323985111","article-title":"Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses","volume":"111","author":"Rookhuizen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.molimm.2018.01.005_bib0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/path.2264","article-title":"The role of TLR activation in inflammation","volume":"214","author":"Sabroe","year":"2008","journal-title":"J. Pathol."},{"issue":"6179","key":"10.1016\/j.molimm.2018.01.005_bib0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2018.01.005_bib0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2018.01.005_bib0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/08820139.2011.604864","article-title":"Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN","volume":"41","author":"Wang","year":"2012","journal-title":"Immunol. Invest."},{"issue":"1","key":"10.1016\/j.molimm.2018.01.005_bib0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10753-012-9526-6","article-title":"Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis","volume":"36","author":"Wang","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.molimm.2018.01.005_bib0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-015-0334-4","article-title":"Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway","volume":"12","author":"Wang","year":"2015","journal-title":"J. Neuroinflam."},{"issue":"10","key":"10.1016\/j.molimm.2018.01.005_bib0180","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.4049\/jimmunol.169.10.5590","article-title":"Effect of suppressive DNA on CpG-induced immune activation","volume":"169","author":"Yamada","year":"2002","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2018.01.005_bib0185","doi-asserted-by":"crossref","first-page":"F1050","DOI":"10.1152\/ajprenal.00461.2007","article-title":"Chloroquine and inhibition of toll-like receptor 9 protect from sepsis-induced acute kidney injury","volume":"294","author":"Yasuda","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.molimm.2018.01.005_bib0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.expneurol.2014.01.024","article-title":"Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma","volume":"254","author":"Zhang","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molimm.2018.01.005_bib0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2016.12.027","article-title":"TLR9 and its signaling pathway in multiple sclerosis","volume":"373","author":"Zhou","year":"2017","journal-title":"J. Neurol. Sci."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018300051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018300051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T22:37:32Z","timestamp":1537828652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018300051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":39,"alternative-id":["S0161589018300051"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2018.01.005","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}